These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 9679456

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Metabolic properties and photosensitizing responsiveness of mono-L-aspartyl chlorin e6 in a mouse tumor model.
    Ferrario A, Kessel D, Gomer CJ.
    Cancer Res; 1992 May 15; 52(10):2890-3. PubMed ID: 1581904
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Photodynamic therapy with mono-L-aspartyl chlorin e6 can cause necrosis of squamous cell carcinoma of tongue: experimental study on an animal model of nude mouse.
    Kobayashi W, Liu Q, Nakagawa H, Sakaki H, Teh B, Matsumiya T, Yoshida H, Imaizumi T, Satoh K, Kimura H.
    Oral Oncol; 2006 Jan 15; 42(1):46-50. PubMed ID: 16266818
    [Abstract] [Full Text] [Related]

  • 7. Photodynamic therapy using mono-L-aspartyl chlorin e6 (Npe6) for the treatment of cutaneous disease: a Phase I clinical study.
    Taber SW, Fingar VH, Coots CT, Wieman TJ.
    Clin Cancer Res; 1998 Nov 15; 4(11):2741-6. PubMed ID: 9829737
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Mono-L-aspartyl chlorin e6 (NPe6) and hematoporphyrin derivative (HpD) in photodynamic therapy administered to a human cholangiocarcinoma model.
    Wong Kee Song LM, Wang KK, Zinsmeister AR.
    Cancer; 1998 Jan 15; 82(2):421-7. PubMed ID: 9445202
    [Abstract] [Full Text] [Related]

  • 10. High expression of GADD-45alpha and VEGF induced tumor recurrence via upregulation of IL-2 after photodynamic therapy using NPe6.
    Ohtani K, Usuda J, Ichinose S, Ishizumi T, Hirata T, Inoue T, Maehara S, Imai K, Kubota M, Tsunoda Y, Yamada M, Tsutsui H, Yamada K, Kuroiwa Y, Furukawa K, Okunaka T, Kato H.
    Int J Oncol; 2008 Feb 15; 32(2):397-403. PubMed ID: 18202762
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Dynamics of photosensitizer in the cell].
    Aizawa K, Kuroiwa Y, Tsuchida T, Xiahedin I, Shibuya H, Saito K.
    Gan To Kagaku Ryoho; 1996 Jan 15; 23(1):22-6. PubMed ID: 8546464
    [Abstract] [Full Text] [Related]

  • 13. CHOP activation by photodynamic therapy increases treatment induced photosensitization.
    Wong S, Luna M, Ferrario A, Gomer CJ.
    Lasers Surg Med; 2004 Jan 15; 35(5):336-41. PubMed ID: 15611953
    [Abstract] [Full Text] [Related]

  • 14. Pilot study of topical delivery of mono-L-aspartyl chlorin e6 (NPe6): implication of topical NPe6-photodynamic therapy.
    Wong TW, Aizawa K, Sheyhedin I, Wushur C, Kato H.
    J Pharmacol Sci; 2003 Oct 15; 93(2):136-42. PubMed ID: 14578580
    [Abstract] [Full Text] [Related]

  • 15. Detection of photodynamic therapy-induced early apoptosis in human salivary gland tumor cells in vitro and in a mouse tumor model.
    Kaneko T, Chiba H, Yasuda T, Kusama K.
    Oral Oncol; 2004 Sep 15; 40(8):787-92. PubMed ID: 15288832
    [Abstract] [Full Text] [Related]

  • 16. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
    Peng Q, Warloe T, Moan J, Godal A, Apricena F, Giercksky KE, Nesland JM.
    Cancer Res; 2001 Aug 01; 61(15):5824-32. PubMed ID: 11479222
    [Abstract] [Full Text] [Related]

  • 17. Low-level light therapy potentiates NPe6-mediated photodynamic therapy in a human osteosarcoma cell line via increased ATP.
    Tsai SR, Yin R, Huang YY, Sheu BC, Lee SC, Hamblin MR.
    Photodiagnosis Photodyn Ther; 2015 Mar 01; 12(1):123-30. PubMed ID: 25462575
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Morphologic evaluation of the antitumor activity of photodynamic therapy (PDT) using mono-L-aspartyl chlorin e6 (NPe6) against uterine cervical carcinoma cell lines.
    Nakamura H, Suzuki Y, Takeichi M, Saito T, Takayama M, Aizawa K.
    Int J Gynecol Cancer; 2002 Mar 01; 12(2):177-86. PubMed ID: 11975677
    [Abstract] [Full Text] [Related]

  • 20. Differential susceptibilities of murine hepatoma 1c1c7 and Tao cells to the lysosomal photosensitizer NPe6: influence of aryl hydrocarbon receptor on lysosomal fragility and protease contents.
    Caruso JA, Mathieu PA, Joiakim A, Leeson B, Kessel D, Sloane BF, Reiners JJ.
    Mol Pharmacol; 2004 Apr 01; 65(4):1016-28. PubMed ID: 15044632
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.